.
MergerLinks Header Logo

New Deal


Announced

Completed

Ally Bridge Group led a $50m funding round in Ceribell.

Synopsis

Ally Bridge Group, a global healthcare investment management firm, led a $50m funding round in Ceribell, a medical device start-up company. "We are excited to partner with Ally Bridge and appreciate the continued support from our existing shareholders. Based on our progress to date, it is clear that the Ceribell Rapid EEG system is improving the quality of care seizure patients receive in the hospital. We look forward to continuing to bring this novel technology to more ICUs and Emergency Departments, as well as developing diagnostic and monitoring solutions for additional neurological indications impacting the lives of critically ill patients," Jane Chao, Founder and CEO Ceribell.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US